The DOI matches its Crossref record; 53 of the 61 references it cites were found in a registry or an index; 29 of the 61 sources its claims cite were checked for support.
Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis
Open accessAbstract
Objectives: This study aimed to pool the efficacy in bowel movement and explore the change of gut microbiota on adult functional constipated patients after probiotics-containing products treatment. Design: Systematic review and meta-analysis. Data sources: PubMed, Cochrane Library for published studies and ClinicalTrials.gov for ‘grey’ researches were independently investigated for randomised controlled trials up to November 2022. Eligibility criteria, data extraction and synthesis: The intervention was probiotics-containing product, either probiotics or synbiotics, while the control was placebo. The risk of bias was conducted. The efficacy in bowel movement was indicated by stool frequency, stool consistency and Patient Assessment of Constipation Symptom (PAC-SYM), while the change of gut microbiota was reviewed through α diversity, β diversity, change/difference in relative abundance and so on. The subgroup analysis, sensitivity analysis and random-effect meta-regression were conducted to explore the heterogeneity. The Grading of Recommendations Assessment Development and Evaluation was conducted to grade the quality of evidence. Results: 17 studies, comprising 1256 participants, were included with perfect agreements between two researchers (kappa statistic=0.797). Compared with placebo, probiotics-containing products significantly increased the stool frequency (weighted mean difference, WMD 0.93, 95% CI 0.47 to 1.40, p=0.000, I ² =84.5%, ‘low’), improved the stool consistency (WMD 0.38, 95% CI 0.05 to 0.70, p=0.023, I²=81.6%, ‘very low’) and reduced the PAC-SYM (WMD −0.28, 95% CI: −0.45 to −0.11, p=0.001, I²=55.7%, ‘very low’). In subgroup analysis, synbiotics was superior to probiotics to increase stool frequency. Probiotics-containing products might not affect α or β diversity, but would increase the relative abundance of specific strain. Conclusions: Probiotics-containing products, significantly increased stool frequency, improved stool consistency, and alleviated functional constipation symptoms. They increased the relative abundance of specific strain. More high-quality head-to-head randomised controlled trials are needed.
Overview
CoChat Summary
TL;DR
In adults with functional constipation, probiotics-containing products (probiotics or synbiotics) significantly increased stool frequency, improved stool consistency, and reduced PAC-SYM scores compared with placebo. Gut microbiota α/β diversity was generally unchanged, but relative abundance of specific supplemented strains often increased.
Key findings
- Across 17 RCTs and 1256 participants, probiotics-containing products increased stool frequency versus placebo (WMD 0.93, 95% CI 0.47 to 1.40, p=0.000, I²=84.5%, GRADE “low”).
- They improved stool consistency (WMD 0.38, 95% CI 0.05 to 0.70, p=0.023, I²=81.6%, GRADE “very low”) and reduced PAC-SYM (WMD −0.28, 95% CI −0.45 to −0.11, p=0.001, I²=55.7%, GRADE “very low”).
- Synbiotics were superior to probiotics for stool frequency (synbiotics WMD 1.25, 95% CI 0.59 to 1.90, p=0.000; probiotics WMD 0.83, 95% CI 0.26 to 1.41, p=0.005); multistrain formula also showed significant efficacy (WMD 1.38, 95% CI 0.94 to 1.82, p=0.000).
- Qualitative review of 8 studies suggested probiotics-containing products might not affect α or β diversity, but often increased relative abundance of specific strains; one study found decreased OTUs and Chao1 in the experimental group.
Methods
- Systematic review and meta-analysis of parallel or cross-over RCTs in adults with functional constipation; intervention was probiotics or synbiotics, control was placebo; outcomes included stool frequency, stool consistency, PAC-SYM, and gut microbiota change.
- Searched PubMed, Cochrane Library, and ClinicalTrials.gov up to November 2022; 17 studies with 1256 participants were included, with agreement between reviewers (kappa=0.797); PROSPERO registration CRD42022381368.
- Pooled continuous outcomes using WMD or SMD with random/fixed-effect models, assessed heterogeneity by I², and performed subgroup analysis, sensitivity analysis, random-effect meta-regression, and GRADE; microbiota changes were qualitatively summarized through α diversity, β diversity, and relative abundance.
Limitations
- Stated: modest sample sizes and high heterogeneity may misestimate efficacy; lack of clear protocols increases possible publication bias; obesity and diet may affect gut microbiota but relevant data were often unavailable; no unified methodology for measuring microbiota effects; negative data are underreported.
- Evident from text: stool frequency and consistency pooled results had high heterogeneity (I²=84.5% and 81.6%, respectively), and GRADE quality was “low” for stool frequency and “very low” for stool consistency and PAC-SYM.
- Evident from text: quantitative syntheses relied on limited study numbers for stool consistency (6 studies) and PAC-SYM (5 studies), and microbiota conclusions came from qualitative review of 8 studies with varied sequencing and analysis methods.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
17 Valid · 4 Not valid · 16 Not checked · 44 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“by subgroup analysis, our pooled results, with similarity to previous researches,12 13 indicated that Bacillus-containing formula might had the best but non-significant efficacy, while multistrains formula had satisfactory and significant efficacy.”
- Also stated in: § Conclusion · plain
“the multistrains formula displays satisfactory and credible efficacy”
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Discussion
What the sources say
- Disputedcites [12] Miller, 2016, Contemporary meta-analysis of short-term Probiotic consumption on gastrointestinal transit, World J Gastroenterol sourceExperimental — accuracy not yet measured
Table 5 (subgroup analysis of intestinal transit time; page not supplied) reports a positive estimated effect for multiple-strain probiotics, but it was not statistically significant (SMD 0.23, 95% CI −0.01 to 0.47; P = 0.06). The paper therefore contradicts the claim of significant efficacy for multistrain formulas. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [13] Zhang, 2020, Meta-analysis of randomized controlled trials of the effects of Probiotics on functional constipation in adults, Clin Nutr source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusion · plain
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“17 studies, comprising 1256 participants, were included with perfect agreements between two researchers (kappa statistic=0.797).”
- Also stated in: § Study characteristics · plain
“Finally, a total of 17 studies, consisting of 1256 participants, were included with perfect agreements between two researchers (kappa statistic=0.797).16–32”
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Abstract > Results
What the sources say
- Not checked — no full text of the sourcecites [16] Cudmore, 2017, A randomised, double-blind, placebo-controlled clinical study: the effects of a Synbiotic, Lepicol, in adults with chronic, functional constipation, Int J Food Sci Nutr source
- Disputedcites [17] Dimidi, 2019, Randomised clinical trial: Bifidobacterium Lactis Ncc2818 Probiotic vs placebo, and impact on gut transit time, symptoms, and gut Microbiology in chronic constipation, Aliment Pharmacol Ther sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports a systematic review of 14 RCTs in adults with chronic constipation, not 17. It describes the cited paper’s own work as a randomized probiotic trial, not the systematic review claimed here; the cited passages do not report 1,256 participants. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Disputedcites [18] Ding, 2016, Efficacy of Synbiotics in patients with slow transit constipation: a prospective randomized trial, Nutrients sourceExperimental — accuracy not yet measured
The Results (section 3.1; page unavailable) describe a single randomized trial: 100 patients were assigned to two groups, and 93 were included in the final analysis. The cited paper does not report a systematic review of 17 trials or 1,256 participants; the citing sentence’s study count and sample size are contrary to its reported design and results. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [19] Fateh, 2011, Synbiotic preparation in men suffering from functional constipation: a randomised controlled trial, Swiss Med Wkly sourceExperimental — accuracy not yet measured
Our copy of Fateh et al. 2011 is a single-centre, 4-week double-blind randomised placebo-controlled trial in adult men with Rome III functional constipation (Patients and methods, p. 2), reporting 107 screened, 66 allocated and 60 analysed (Results, p. 3) — so it does qualify as one of the adult functional-constipation RCTs a pooled review would include, but it supplies none of the figures attributed here. Searches for '17 studies', '1256 participants' and a kappa/inter-reviewer agreement statistic returned no passage: the paper runs no systematic review of its own and states no inclusion totals. The only systematic review it mentions is Chmielewska & Szajewska 2010 (ref. 20), cited in the Introduction (p. 1) and Discussion (p. 5) solely for its conclusion that evidence is insufficient, with no number of studies or patients given. The aggregate counts therefore rest on nothing in this source. (LLM, conf=0.72)
- Disputedcites [20] Ito, 2022, Do Synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: randomized, double-blind, placebo-controlled trial, Medicine sourceExperimental — accuracy not yet measured
The Abstract (Study) describes a single randomized trial enrolling 69 healthy adults with a tendency toward constipation, not a systematic review of 17 trials and 1,256 patients. The Materials and methods (Participants) also state that people diagnosed with constipation or meeting Rome IV criteria were excluded. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [21] Kang, 2021, Spore-forming Bacillus coagulans SNZ 1969 improved intestinal motility and constipation perception mediated by microbial alterations in healthy adults with mild intermittent constipation: a randomized controlled trial, Food Res Int source
- Not checked — no full text of the sourcecites [22] Kim, 2021, Effects of ID-Hws1000 on the perception of bowel activity and microbiome in subjects with functional constipation: a randomized, double-blind placebo-controlled study, J Med Food source
- Disputedcites [23] Kondo, 2013, Modulatory effects of bifidobacterium longum Bb536 on defecation in elderly patients receiving enteral feeding, World J Gastroenterol sourceExperimental — accuracy not yet measured
Our copy of Kondo et al. 2013 is a primary intervention study, not a systematic review: the Abstract (Methods) and the 'Clinical trials' section state that only two double-blind, placebo-controlled trials were performed, randomizing 83 patients (Trial 1) and 123 patients (Trial 2) — 206 elderly enteral-fed inpatients in total, not 17 studies with 1256 participants. The DISCUSSION likewise lists 'evaluation using two successive studies' as a strength, and no passage mentions a systematic search, pooled RCTs, functional constipation in general adults, or an inter-rater kappa statistic. The population is also different (long-term tube-fed Japanese inpatients aged 65-102 with low/normal/high defecation frequency), so the claim as attributed is contradicted by the source's own design and numbers. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [24] Madempudi, 2020, Bacillus Coagulans unique Is2 in constipation: A double-blind, placebo-controlled study, Probiotics Antimicrob Proteins source
- Could not verifycites [25] Magro, 2014, Effect of yogurt containing polydextrose, lactobacillus acidophilus NCFM and bifidobacterium lactis Hn019: a randomized, double-blind, controlled study in chronic constipation, Nutr J sourceExperimental — accuracy not yet measured
The Results report 47 participants in this yogurt trial, while the References list a separate systematic review. Our copy does not state that a review included 17 trials or 1,256 adults; searches for those figures and the reported agreement statistic found no supporting passage. (LLM, conf=0.77)
plainn = 1,256- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Study characteristics · plain
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“by subgroup analysis, our pooled results, with similarity to previous researches,12 13 indicated that Bacillus-containing formula might had the best but non-significant efficacy, while multistrains formula had satisfactory and significant efficacy.”
- Also stated in: § Conclusion · hedged
“Bacillus-containing formula exhibits promising but non-significant efficacy, and requires further validation”
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Discussion
What the sources say
- Disputedcites [12] Miller, 2016, Contemporary meta-analysis of short-term Probiotic consumption on gastrointestinal transit, World J Gastroenterol sourceExperimental — accuracy not yet measured
The strain subgroup analysis (Table 7) identifies B. lactis HN019 and B. lactis DN-173 010 as the most efficacious strains, with statistically significant effects. The Discussion also says single-strain probiotics were more efficacious than multiple-strain probiotics. The paper does not report a Bacillus-containing formula as best but nonsignificant; B. lactis is Bifidobacterium, not Bacillus. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [13] Zhang, 2020, Meta-analysis of randomized controlled trials of the effects of Probiotics on functional constipation in adults, Clin Nutr source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusion · hedged
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“while Miller et al found, by subgroup analysis, that treatment containing Lactobacillus and Bifidobacterium had significant higher improvement than treatment containing Lactobacillus or Bifidobacterium only.35”
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Discussion
What the sources say
- Disputedcites [35] Miller, 2017, Effects of Probiotic-containing products on stool frequency and intestinal transit in Constipated adults: systematic review and meta-analysis of randomized controlled trials, Ann Gastroenterol sourceExperimental — accuracy not yet measured
In the Results sections on stool frequency and intestinal transit (page unavailable), the combined-product subgroup has numerically larger improvements than either single-genus subgroup. But the paper explicitly says probiotic species did not statistically influence either outcome; it does not find a significant advantage for the combination over the single-genus products. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“Gut microbiota, which comprises a complex community of micro-organisms inhabiting the gastrointestinal tract, including bacteria, viruses, fungi and other micro-organisms, plays a crucial role in gut motility.6”
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Introduction
What the sources say
- Supportedcites [6] source
The Luminal factors section states that gastrointestinal microbiota play a vital role in gut motility and describes changes in transit and contractility when microbiota are absent or introduced. This directly supports the attributed claim. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
33 more claims · 7 with their cited sources checked
Create a free account to see all 81 claims and to verify the 2 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 25
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Results > Efficacy
“the duration of treatment (from 1 to 8 weeks)”
§ Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis > Results > Study characteristics
“| Ding, 2016China18 | R.D.P.Ro. III | 48/4562.5%/64.4% | 47.2 (10.7)/48.3 (11.3)22.6 (1.1)/22.8 (1.1) | En., B. and L.0.1 | pectin | 12 |”
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218 · cited 1×
“14 As mentioned above, multistrains probiotics demonstrated superior efficacy compared with single-strain ones; therefore, it was worth investigating whether synbiotics conferred even greater efficacy than probiotics alone.”
BackgroundIndigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614 · cited 1×
“Fei Ding http://orcid.org/0000-0002-9396-8023 Mengyang Hu http://orcid.org/0000-0001-6338-8151 Yifei Ding http://orcid.org/0000-0001-9920-2320 Yingying Meng http://orcid.org/0000-0002-8594-4734 Yanchao Zhao http://orcid.org/0000-0002-2710-0824”
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 1×
“Fei Ding http://orcid.org/0000-0002-9396-8023 Mengyang Hu http://orcid.org/0000-0001-6338-8151 Yifei Ding http://orcid.org/0000-0001-9920-2320 Yingying Meng http://orcid.org/0000-0002-8594-4734 Yanchao Zhao http://orcid.org/0000-0002-2710-0824”
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196 · cited 1×
“16–21 24–32 Among these studies, two studies measured stool frequency by the criteria called ‘CSBM’ 17 26 and one by ‘SBM’, 30 while the remaining didn’t describe specific measurement methodology of stool defecation.”
MethodBrożek, J. L., Akl, E. A., Alonso‐Coello, P., Lang, D., Jaeschke, R., Williams, J. W., Phillips, B., Lelgemann, M., Lethaby, A., Bousquet, J., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.01973.x · Cited by 894
Mechanisms, evaluation, and management of chronic constipation
Bharucha, A. E., & Lacy, B. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.034 · Cited by 655
Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0300-5 · Cited by 561 · cited 1×
“Fei Ding http://orcid.org/0000-0002-9396-8023 Mengyang Hu http://orcid.org/0000-0001-6338-8151 Yifei Ding http://orcid.org/0000-0001-9920-2320 Yingying Meng http://orcid.org/0000-0002-8594-4734 Yanchao Zhao http://orcid.org/0000-0002-2710-0824”
Dimidi, E., Christodoulides, S., Scott, S. M., & Whelan, K. (2017) · Advances in Nutrition · doi:10.3945/an.116.014407 · Cited by 468
Barberio, B., Judge, C., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00111-4 · Cited by 422
Cited by
Functional yogurt: a comprehensive review of its nutritional composition and health benefits
Pannerchelvan, S., Rios‐Solis, L., Wasoh, H., Sobri, Z. M., Wong, F. W. F., Mohamed, M. S., Mohamad, R., & Halim, M. (2024) · Food & Function · doi:10.1039/d4fo03671a · Cited by 90
“However, osmotic laxatives like lactulose may lose efficacy with prolonged use, and stimulative laxatives can lead to melanosis coli (Ding et al., 2024).”
InfluentialJohnson, B. V. B., Milstead, M., Kreider, R., & Jones, R. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100209 · Cited by 27
“Probiotics, defined as live microorganisms, have been shown to positively influence the gut microbiome, metabolic function, and overall health [97].”
Overview of the Efficacy of Using Probiotics for Neurosurgical and Potential Neurosurgical Patients
Fijan, S., & Šmigoc, T. (2024) · Microorganisms · doi:10.3390/microorganisms12071361 · Cited by 12
“Several systematic reviews have shown that probiotic supplementation can significantly improve gastrointestinal function and relieve functional constipation thus improving disease burden [51–53].”
BackgroundTang, X., Huang, Y., Jiang, T., Wu, J., Wang, K., & Wu, W. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04387-9 · Cited by 17
Zhou, X.-J., Chen, J.-L., Hu, C.-F., Li, Z.-K., Zheng, H.-B., Ding, T.-N., Chen, Y., Zhu, Y., Li, J.-N., Fu, Q., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1834916 · Cited by 6
Metadata
- Authors
- Ding, F., Hu, M., Ding, Y., Meng, Y., & Zhao, Y.
- Affiliations
- Yancheng Third People's Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Department of Gastroenterology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
- Corresponding author
- Meng, Yingying
- Zhao, Yanchao
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2024-01
- Volume
- 14
- Issue
- 1
- Pages
- e074557
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC10806726
- OpenAlex
- W4390988255
- Cited by
- 22
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 3
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- functional constipation, probiotics, synbiotics, gut microbiota, defecation, stool frequency, stool consistency, alpha diversity, beta diversity, adults
- MeSH terms
- Gastrointestinal Microbiome, Adult, Constipation, Defecation, Humans, Probiotics, Synbiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2023-074557
- The paper
- Ding, F., Hu, M., Ding, Y., Meng, Y., & Zhao, Y. (2024). Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2023-074557
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.